Language Selector

    Apply for Vaccine Development Services and Training now

    Published on 03 April 2020
    Author: Nicole Wyss, National Contact Point Research Infrastructures

    TRANSVAC, the collaborative infrastructure project designed to accelerate vaccine development by enhancing European vaccine research and training, offers transnational access. Call open now until 15 April 2020.

    Researchers developing vaccine candidates against COVID19 are encourage to apply and benefit from all TRANSVAC2 services, such as:

    • Adjuvant formulation - Vaccine Formulation Institute and Helmholtz Centre for Infection Research
    • Structural Biology - INSTRUCT
    • Animal models - CEA, BPRC, IRTA-CReSA  and Helmholtz Centre for Infection Research
    • Clinical Trial Support - ECRIN (European Clinical Research Infrastructure Network)
    • Regulatory support - EATRIS and European Vaccine Initiative

    Call for Transnational Access deadline: 15 April 2020.

    More information